It was reported that at (b)(6), the patient was treated with unacid (sultamicillin) following phlebitis from the suspect device.Although it is unknown who placed and operated the device, it was reported that the rescue service at the facility places 50% of the vascular access devices.
|
Result - twelve (b)(4) samples were received for evaluation on march 15, 2016, including 6 actual and 6 representative samples.The 6 representative (sealed) samples were visually inspected and noted that the packages are fully sealed with no seal damage.Based on the evaluation, the samples received did not observe any visual defect.The 6 actual (contaminated) samples have been used hence bd is unable to further investigate.Lot 5265426 was produced in october 2015.Lot 5030237 was produced in february 2015.No similar complaint has been received on the lot numbers reported in this incident.A review of the device history revealed no abnormalities or quality notifications during production of the reported lot numbers.No abnormality was reported in the certificate of irradiation and lal for the complaint lots.The preventive maintenance, calibration, and equipment were reviewed and no abnormality was observed that could have influenced the issue.Conclusion - bd was not able to duplicate or confirm the customer¿s indicated failure mode.Based on the evaluation, the representative (sealed) samples received were visually inspected and the packages were fully sealed with no seal damage.Based on the evaluation, the samples received did not observe any visual defect.The actual (contaminated) samples had been used hence bd was unable to further investigate.An absolute root cause for this incident cannot be determined.
|